"Interleukin-17" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A proinflammatory cytokine produced primarily by T-LYMPHOCYTES or their precursors. Several subtypes of interleukin-17 have been identified, each of which is a product of a unique gene.
| Descriptor ID |
D020381
|
| MeSH Number(s) |
D12.644.276.374.465.517 D12.776.467.374.465.517 D23.529.374.465.517
|
| Concept/Terms |
Interleukin-17F- Interleukin-17F
- Interleukin 17F
- IL-17F
- Cytokine ML-1
- Cytokine ML 1
Interleukin-17C- Interleukin-17C
- Interleukin 17C
- IL-17C
- Cytokine CX2
- CX2, Cytokine
Interleukin-17E- Interleukin-17E
- Interleukin 17E
- Interleukin-25
- Interleukin 25
- IL-17E
- IL 17E
Interleukin-17A- Interleukin-17A
- Interleukin 17A
- Cytotoxic T lymphocyte-Associated Antigen 8
- Cytotoxic T lymphocyte Associated Antigen 8
- IL-17A
- CTLA8
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-17".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-17".
This graph shows the total number of publications written about "Interleukin-17" by people in this website by year, and whether "Interleukin-17" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 3 |
| 2004 | 2 | 1 | 3 |
| 2005 | 3 | 0 | 3 |
| 2006 | 4 | 0 | 4 |
| 2007 | 6 | 3 | 9 |
| 2008 | 16 | 8 | 24 |
| 2009 | 15 | 20 | 35 |
| 2010 | 17 | 13 | 30 |
| 2011 | 13 | 13 | 26 |
| 2012 | 16 | 12 | 28 |
| 2013 | 17 | 15 | 32 |
| 2014 | 20 | 16 | 36 |
| 2015 | 21 | 13 | 34 |
| 2016 | 26 | 18 | 44 |
| 2017 | 12 | 15 | 27 |
| 2018 | 15 | 16 | 31 |
| 2019 | 18 | 18 | 36 |
| 2020 | 12 | 15 | 27 |
| 2021 | 10 | 8 | 18 |
| 2022 | 2 | 13 | 15 |
| 2023 | 2 | 13 | 15 |
| 2024 | 11 | 12 | 23 |
| 2025 | 1 | 0 | 1 |
Below are the most recent publications written about "Interleukin-17" by people in Profiles.
-
The Inflammatory Landscape of a Whole-Tissue Explant Model of Hidradenitis Suppurativa. Exp Dermatol. 2025 Feb; 34(2):e70057.
-
Pathobiont-induced suppressive immune imprints thwart T cell vaccine responses. Nat Commun. 2024 Dec 16; 15(1):10335.
-
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials. Ann Rheum Dis. 2024 Nov 14; 83(12):1722-1730.
-
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis. Rheumatology (Oxford). 2024 11 01; 63(11):3115-3123.
-
Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis. Nature. 2024 Dec; 636(8041):206-214.
-
Pathogenesis of psoriatic arthritis: new insights from a bone marrow perspective. Curr Opin Rheumatol. 2025 Mar 01; 37(2):136-141.
-
Cord blood cytokine profiles in children later diagnosed with autism spectrum disorder: Results from the prospective MARBLES study. Brain Behav Immun. 2024 Nov; 122:339-344.
-
Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies. Eur Respir J. 2024 Aug; 64(2).
-
IL-13 and IL-17A activate β1 integrin through an NF-kB/Rho kinase/PIP5K1γ pathway to enhance force transmission in airway smooth muscle. Proc Natl Acad Sci U S A. 2024 Aug 20; 121(34):e2401251121.
-
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel. J Drugs Dermatol. 2024 Aug 01; 23(8):592-599.